Synapse - Matthew Fury

Results (102)

A phase I trial of pemetrexed plus gemcitabine given biweekly with B-vitamin support in solid tumor malignancies or advanced epithelial ovarian cancer

Journal Article

Hensley, M. L.; Larkin, J.; Fury, M.; Gerst, S.; Tai, D. F.; Sabbatini, P.; Konner, J.; Orlando, M.; Goss, T. L.; Aghajanian, C. A.
Clinical Cancer Research (2008)

Fulltext@MSK | Save

A phase-I trial of the epidermal growth factor receptor directed bispecific antibody MDX-447 without and with recombinant human granulocyte-colony stimulating factor in patients with advanced solid tumors

Journal Article

Fury, M. G.; Lipton, A.; Smith, K. M.; Winston, C. B.; Pfister, D. G.
Cancer Immunology, Immunotherapy (2008)

Fulltext@MSK | Save

Single agent bevacizumab and bevacizumab in combination with docetaxel and cisplatin as induction therapy for resectable IB-IIIA non-small cell lung cancer

Meeting Abstract

Rizvi, N. A.; Rusch, V.; Zhao, B.; Senturk, E.; Schwartz, L.; Fury, M.; Downey, R.; Rizk, N.; Krug, L.; Kris, M. G.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

Phase I study of pemetrexed (P) plus gemcitabine (G) in advanced solid tumors (ST)

Meeting Abstract

Fury, M. G.; Larkin, J.; Gerst, S. R.; Sabbatini, P.; Konner, J.; Orlando, M.; Tai, D. F.; Goss, T.; Aghajanian, C.; Hensley, M. L.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) as a predictor of response in head and neck squamous cell carcinoma (HNSCC)

Meeting Abstract

Dave, A.; Fury, M.; Lee, N.; Stambuk, H.; Wang, Y.; Karimi, S.; Pfister, D.; Koutcher, J.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors

Journal Article

Fury, M. G.; Solit, D. B.; Su, Y. B.; Rosen, N.; Sirotnak, F. M.; Smith, R. P.; Azzoli, C. G.; Gomez, J. E.; Miller, V. A.; Kris, M. G.; more...
Cancer Chemotherapy and Pharmacology (2007)

Fulltext@MSK | Save

A Phase II study of SU5416 in patients with advanced or recurrent head and neck cancers

Journal Article

Fury, M. G.; Zahalsky, A.; Wong, R.; Venkatraman, E.; Lis, E.; Hann, L.; Aliff, T.; Gerald, W.; Fleisher, M.; Pfister, D. G.
Investigational New Drugs (2007)

Fulltext@MSK | Save

A phase II study of single agent depsipeptide (DEP) in patients (pts) with radio-active iodine (RAI)-refractory, metastatic, thyroid carcinoma: Preliminary toxicity and efficacy experience